270 related articles for article (PubMed ID: 34951997)
61. Modulation of cell growth and matrix metalloproteinase-2 activation of oral squamous cell carcinoma as a function of culture condition with type I collagen.
Kinsenn H; Sato H; Furukawa M; Yoshizaki T
Acta Otolaryngol; 2003 Oct; 123(8):987-93. PubMed ID: 14606604
[TBL] [Abstract][Full Text] [Related]
62. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.
Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L
Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989
[TBL] [Abstract][Full Text] [Related]
63. Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7.
Jung DW; Che ZM; Kim J; Kim K; Kim KY; Williams D; Kim J
Int J Cancer; 2010 Jul; 127(2):332-44. PubMed ID: 19937793
[TBL] [Abstract][Full Text] [Related]
64. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
65. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
66. Sp1 promotes cell migration and invasion in oral squamous cell carcinoma by upregulating Annexin A2 transcription.
Liu XB; Wang J; Li K; Fan XN
Mol Cell Probes; 2019 Aug; 46():101417. PubMed ID: 31254619
[TBL] [Abstract][Full Text] [Related]
67. May High MMP-2 and TIMP-2 Expressions Increase or Decrease the Aggressivity of Oral Cancer?
Shrestha B; Bajracharya D; Byatnal AA; Kamath A; Radhakrishnan R
Pathol Oncol Res; 2017 Jan; 23(1):197-206. PubMed ID: 27853937
[TBL] [Abstract][Full Text] [Related]
68. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
[TBL] [Abstract][Full Text] [Related]
69. MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway.
He J; Ye W; Kou N; Chen K; Cui B; Zhang X; Hu S; Liu T; Kang L; Li X
J Cell Mol Med; 2020 Jan; 24(1):841-849. PubMed ID: 31680452
[TBL] [Abstract][Full Text] [Related]
70. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
[TBL] [Abstract][Full Text] [Related]
71. Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma.
Shang ZJ; Ethunandan M; Górecki DC; Brennan PA
Oral Oncol; 2008 Dec; 44(12):1139-46. PubMed ID: 18487074
[TBL] [Abstract][Full Text] [Related]
72. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
73. Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells.
Komine-Aizawa S; Aizawa S; Takano C; Hayakawa S
Immunol Med; 2020 Sep; 43(3):121-129. PubMed ID: 32546118
[TBL] [Abstract][Full Text] [Related]
74.
Zhang J; Wu J; Chen Y; Zhang W
Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
[TBL] [Abstract][Full Text] [Related]
75. SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
Takahara T; Kasamatsu A; Yamatoji M; Iyoda M; Kasama H; Saito T; Takeuchi S; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Exp Cell Res; 2017 Mar; 352(2):357-363. PubMed ID: 28237246
[TBL] [Abstract][Full Text] [Related]
76. circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling.
Liu J; Jiang X; Zou A; Mai Z; Huang Z; Sun L; Zhao J
Cancer Res; 2021 Jan; 81(2):344-355. PubMed ID: 33203701
[TBL] [Abstract][Full Text] [Related]
77. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
[TBL] [Abstract][Full Text] [Related]
78. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.
Gao L; Dong J; Zhang N; Le Z; Ren W; Li S; Li F; Song J; Wang Q; Dou Z; Park SY; Zhi K
Anticancer Agents Med Chem; 2019; 19(2):248-255. PubMed ID: 30378503
[TBL] [Abstract][Full Text] [Related]
79. Activation of Toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma.
Ruan M; Zhang Z; Li S; Yan M; Liu S; Yang W; Wang L; Zhang C
PLoS One; 2014; 9(3):e92748. PubMed ID: 24658023
[TBL] [Abstract][Full Text] [Related]
80. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
